The healthcare industry is experiencing a fundamental transformation — a shift from the traditional fee-for-service model to ...

Mechelen, Belgium; November 3, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present new and updated data for CAR T-cell therapy candidate, GLPG51011, at the ...

Discover Revvity, Inc.’s latest earnings, cloud growth, and $1B buyback. Click for my updated look at RVTY stock and why I ...

Professionals have the satisfaction of knowing their efforts lead to tangible improvements in lives and communities.

High-paying remote finance director jobs often involve managing accounting and financial control functions, establishing ...

Here’s a fresh 160-character meta description based on the updated article: Osterweis Capital Management reviews Q3 results ...

Sisense, the leader in AI-driven analytics that transforms enterprise data into a competitive edge, today released new research revealing a "churn paradox" in the product analytics market. The study, ...

YourStory presents the daily news roundup from the Indian startup ecosystem and beyond. Here's the roundup for Thursday, ...

NANOBIOTIX (Euronext: NANO -- NASDAQ: NBTX - the "Company''), a late-stage clinical biotechnology company pioneering physics-based approaches ...

Douthat: It’s worth noting that your company is named for seeing stones used to view things at a very long distance in J.R.R.

First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory multiple myeloma 450 million cell dose is the recommended ...